• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中草药在肝细胞癌中的预防和治疗作用

Preventive and therapeutic role of traditional Chinese herbal medicine in hepatocellular carcinoma.

作者信息

Ting Chin-Tsung, Li Wan-Chun, Chen Chang-Yi, Tsai Tung-Hu

机构信息

Division of Gastrointestinal Surgery, Department of Surgery, Taipei City Hospital (Renai Branch), Taipei, Taiwan, ROC; Institute of Traditional Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan, ROC.

Institute of Oral Biology, School of Dentistry, National Yang-Ming University, Taipei, Taiwan, ROC; Department of Dentistry, School of Dentistry, National Yang-Ming University, Taipei, Taiwan, ROC; Department of Education and Research, Taipei City Hospital, Taipei, Taiwan, ROC.

出版信息

J Chin Med Assoc. 2015 Mar;78(3):139-44. doi: 10.1016/j.jcma.2014.09.003. Epub 2014 Oct 25.

DOI:10.1016/j.jcma.2014.09.003
PMID:25447209
Abstract

Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies worldwide. The clinical management of HCC remains a substantial challenge. Although surgical resection of tumor tissues seems promising, a high recurrence and/or metastasis rate accounting for disease-related death has led to an urgent need for improved postsurgical preventive/therapeutic clinical intervention. Developing advanced target-therapy agents such as sorafenib appears to be the only effective clinical intervention for patients with HCC to date, but only limited trials have been conducted in this regard. Because of their enhanced preventive/therapeutic effects, traditional Chinese herbal medicine (CHM)-derived compounds are considered suitable agents for HCC treatment. The CHM-derived compounds also possess multilevel, multitarget, and coordinated intervention effects, making them ideal candidates for inhibition of tumor progression and HCC metastasis. This article reviews the anticancer activity of various CHMs with the hope of providing a better understanding of how to best use CHM for HCC treatment.

摘要

肝细胞癌(HCC)是全球最常见的恶性肿瘤之一。HCC的临床管理仍然是一项重大挑战。尽管肿瘤组织的手术切除似乎很有前景,但高复发率和/或转移率导致与疾病相关的死亡,这使得迫切需要改进术后预防/治疗性临床干预措施。开发像索拉非尼这样的先进靶向治疗药物似乎是迄今为止对HCC患者唯一有效的临床干预措施,但在这方面仅进行了有限的试验。由于其增强的预防/治疗效果,源自传统中药(CHM)的化合物被认为是治疗HCC的合适药物。源自CHM的化合物还具有多层次、多靶点和协同干预作用,使其成为抑制肿瘤进展和HCC转移的理想候选药物。本文综述了各种CHM的抗癌活性,希望能更好地理解如何最好地将CHM用于HCC治疗。

相似文献

1
Preventive and therapeutic role of traditional Chinese herbal medicine in hepatocellular carcinoma.中草药在肝细胞癌中的预防和治疗作用
J Chin Med Assoc. 2015 Mar;78(3):139-44. doi: 10.1016/j.jcma.2014.09.003. Epub 2014 Oct 25.
2
Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma.中药来源的化合物在癌症治疗中的应用:以肝细胞癌为例。
J Ethnopharmacol. 2013 Oct 7;149(3):601-12. doi: 10.1016/j.jep.2013.07.030. Epub 2013 Aug 1.
3
A Cohort Study to Examine the Use of Chinese Herbal Medicine in Combination With Conventional Therapies for Patients With Hepatocellular Carcinoma in China.一项在中国开展的队列研究,旨在考察中药与传统疗法联合用于肝细胞癌患者的情况。
Integr Cancer Ther. 2018 Sep;17(3):902-911. doi: 10.1177/1534735418775819. Epub 2018 May 18.
4
A Case of Recurrent Hepatocellular Carcinoma Acquiring Complete Remission of Target Lesion With Treatment With Traditional Chinese Medicine.一例复发性肝细胞癌经中医治疗后靶病灶完全缓解的病例
Integr Cancer Ther. 2017 Dec;16(4):597-604. doi: 10.1177/1534735416660617. Epub 2016 Jul 21.
5
Preventive and Therapeutic Effects of Chinese Herbal Compounds against Hepatocellular Carcinoma.中药复方对肝细胞癌的预防和治疗作用
Molecules. 2016 Jan 27;21(2):142. doi: 10.3390/molecules21020142.
6
Integrating Chinese and Western medicines reduced the incidence of hepatocellular carcinoma in patients with diabetes mellitus: A Taiwanese population-based cohort study.中西医结合降低了糖尿病患者肝细胞癌的发病率:一项基于台湾人群的队列研究。
Complement Ther Med. 2020 Mar;49:102332. doi: 10.1016/j.ctim.2020.102332. Epub 2020 Feb 29.
7
Prescription frequency and patterns of Chinese herbal medicine for liver cancer patients in Taiwan: a cross-sectional analysis of the National Health Insurance Research Database.台湾肝癌患者的中药处方频率及模式:基于全民健康保险研究数据库的横断面分析
BMC Complement Altern Med. 2017 Feb 20;17(1):118. doi: 10.1186/s12906-017-1628-0.
8
The Characteristics and Mortality of Chinese Herbal Medicine Users among Newly Diagnosed Inoperable Huge Hepatocellular Carcinoma (≥10 cm) Patients: A Retrospective Cohort Study with Exploration of Core Herbs.中药使用者的特征和新发不可切除巨大肝癌(≥10cm)患者的死亡率:一项基于核心草药的回顾性队列研究
Int J Environ Res Public Health. 2022 Sep 30;19(19):12480. doi: 10.3390/ijerph191912480.
9
Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma.辅助中药治疗对肝癌患者长期生存的影响。
Phytomedicine. 2019 Sep;62:152930. doi: 10.1016/j.phymed.2019.152930. Epub 2019 May 11.
10
Pharmacological Effects of Active Components of Chinese Herbal Medicine in the Treatment of Alzheimer's Disease: A Review.中药活性成分治疗阿尔茨海默病的药理作用:综述。
Am J Chin Med. 2016;44(8):1525-1541. doi: 10.1142/S0192415X16500853. Epub 2016 Nov 16.

引用本文的文献

1
Curcumin and Its Derivatives in Hepatology: Therapeutic Potential and Advances in Nanoparticle Formulations.姜黄素及其衍生物在肝病学中的应用:纳米颗粒制剂的治疗潜力与进展
Cancers (Basel). 2025 Feb 1;17(3):484. doi: 10.3390/cancers17030484.
2
Exploring a new chapter in traditional Chinese medicine: The potential of in liver cancer treatment.探索中医新篇章:[具体内容]在肝癌治疗中的潜力。 (注:原文中“in liver cancer treatment”前似乎缺失关键信息)
World J Clin Oncol. 2024 Dec 24;15(12):1520-1527. doi: 10.5306/wjco.v15.i12.1520.
3
Evaluation of the Efficacy, Safety, and Clinical Outcomes of Ginsenosides as Adjuvant Therapy in Hepatocellular Carcinoma: A Meta-Analysis and Systematic Review.
人参皂苷作为辅助治疗肝细胞癌的疗效、安全性和临床结局的评价:荟萃分析和系统评价。
Integr Cancer Ther. 2024 Jan-Dec;23:15347354241293790. doi: 10.1177/15347354241293790.
4
Mitoepigenetics pathways and natural compounds: a dual approach to combatting hepatocellular carcinoma.线粒体表观遗传学途径和天然化合物:双重方法对抗肝细胞癌。
Med Oncol. 2024 Oct 27;41(12):302. doi: 10.1007/s12032-024-02538-8.
5
Advancements in Utilizing Natural Compounds for Modulating Autophagy in Liver Cancer: Molecular Mechanisms and Therapeutic Targets.利用天然化合物调控肝癌自噬的研究进展:分子机制和治疗靶点。
Cells. 2024 Jul 12;13(14):1186. doi: 10.3390/cells13141186.
6
A comprehensive review of phytoconstituents in liver cancer prevention and treatment: targeting insights into molecular signaling pathways.肝癌防治中植物成分的综合述评:靶向分子信号通路的见解。
Med Oncol. 2024 May 4;41(6):134. doi: 10.1007/s12032-024-02333-5.
7
Transcriptome profile and its partly verification of human hepatocellular carcinoma cells exposed to Yuzhizi () seed extract.转录组谱及其对人肝癌细胞暴露于郁李仁种子提取物的部分验证。
J Tradit Chin Med. 2022 Dec;42(6):922-931. doi: 10.19852/j.cnki.jtcm.20220817.002.
8
The Characteristics and Mortality of Chinese Herbal Medicine Users among Newly Diagnosed Inoperable Huge Hepatocellular Carcinoma (≥10 cm) Patients: A Retrospective Cohort Study with Exploration of Core Herbs.中药使用者的特征和新发不可切除巨大肝癌(≥10cm)患者的死亡率:一项基于核心草药的回顾性队列研究
Int J Environ Res Public Health. 2022 Sep 30;19(19):12480. doi: 10.3390/ijerph191912480.
9
Recent Progress in Understanding the Action of Natural Compounds at Novel Therapeutic Drug Targets for the Treatment of Liver Cancer.天然化合物作用于肝癌治疗新治疗药物靶点的研究进展
Front Oncol. 2022 Jan 26;11:795548. doi: 10.3389/fonc.2021.795548. eCollection 2021.
10
Evaluation of anticancer effects of Juniperus communis extract on hepatocellular carcinoma cells in vitro and in vivo.评价杜松提取物在体外和体内对肝癌细胞的抗癌作用。
Biosci Rep. 2021 Jul 30;41(7). doi: 10.1042/BSR20211143.